Bafna Pharma.

{
  "main_header": {
    "sid": 852453,
    "name": "Bafna Pharma.",
    "stock_name": "Bafna Pharma.",
    "full_name": "Bafna Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/bafna-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "166.25",
    "chg": -8.7,
    "chgp": "-4.97%",
    "dir": -1,
    "prev_price": "174.95",
    "mcapval": "393.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532989,
    "symbol": "BAFNAPH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE878I01022",
    "curr_date": "Jun 12, 12:54 PM",
    "curr_time": "12:58 PM",
    "last_traded_at": "Jun 12, 12:54 PM IST",
    "bse_nse_vol": "60.03 k",
    "exc_status": "Active",
    "traded_date": "Jun 12, 2026",
    "traded_date_str": "2026 06 12",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bafna-pharma-852453-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4048710",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_stocks_hitting_lower_circuit_4048710.png",
        "date": "2026-06-12 10:00:14",
        "description": "At Rs 165.45, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 5.0% on 12 Jun 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4046290",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_stocks_hitting_lower_circuit_4046290.png",
        "date": "2026-06-11 10:00:22",
        "description": "At Rs 157.57, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 5.0% on 11 Jun 2026, with unfilled sell orders and a frozen price, signalling a day dominated by supply overwhelming demand."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Forms Golden Cross Amid Mixed Technical Signals and Recent Price Drop",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4044710",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_goldencross_4044710.png",
        "date": "2026-06-10 18:00:48",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Bafna Pharmaceuticals Ltd, signalling a golden cross on 10 Jun 2026. However, the stock declined 4.97% on the day the cross formed, while some technical indicators present a mixed picture. This divergence between the moving averages and price action calls for a closer examination of the signal's reliability."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bafna-pharmaceuticals-ltd-is-rated-sell-4044028",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_mojoScore_4044028.png",
        "date": "2026-06-10 10:10:27",
        "description": "Bafna Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 10 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 4.99% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4043812",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_stocks_hitting_lower_circuit_4043812.png",
        "date": "2026-06-10 10:00:16",
        "description": "At Rs 165.86, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 4.99% on 10 Jun 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 10% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-amid-robust-buying-pressure-4040770",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_stocks_hitting_upper_circuit_4040770.png",
        "date": "2026-06-09 10:00:16",
        "description": "At Rs 213.36, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 10% on 9 Jun 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 215.7",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs2157-4040671",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_priceRelatedfactors_4040671.png",
        "date": "2026-06-09 09:40:32",
        "description": "Surging past its previous peaks, Bafna Pharmaceuticals Ltd touched a fresh 52-week high of Rs 215.7 on 09 Jun 2026, marking a remarkable rally of 186.47% over the past year. This milestone comes amid a sustained seven-day winning streak, underscoring the stock’s robust momentum despite a broadly subdued market backdrop."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 10.0% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-momentum-4038100",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_stocks_hitting_upper_circuit_4038100.png",
        "date": "2026-06-08 10:00:15",
        "description": "At Rs 193.97, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 10.0% on 8 Jun 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-momentum-4035765",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_stocks_hitting_upper_circuit_4035765.png",
        "date": "2026-06-04 10:00:22",
        "description": "At Rs 160.31, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5% on 4 Jun 2026, with buyers queuing and no sellers willing to part with shares."
      }
    ],
    "total": 330,
    "sid": "852453",
    "stock_news_url": "https://www.marketsmojo.com/news/bafna-pharmaceuticals-852453"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "01-Jun-2026",
      "details": "Newspaper Publication for the Audited Financial Results of the Company for the Quarter & Year ended March 31 2026 as published in Financial Express and Makkal Kural on May 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On May 29 2026",
      "datetime": "29-May-2026",
      "details": "We hereby inform you that the Board of Directors in their meeting held on May 29 2026 inter-alia considered and approved the Audited Financial Results of the Company along with the Auditors Report issued by the Statutory Auditors of the Company for the Quarter and Year ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Audited Financial Results For Quarter And Year Ended March 31 2026",
      "datetime": "29-May-2026",
      "details": "We herewith enclose the Audited Financial Results of the Company along with the Statutory Auditors Report for the Quarter and Year ended March 31 2026 as approved by the Board of Directors of the Company at its meeting held on May 29 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bafna Pharmaceuticals Ltd has declared <strong>6%</strong> dividend, ex-date: 19 Sep 13",
          "dt": "2013-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight

2026-06-12 10:00:14

At Rs 165.45, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 5.0% on 12 Jun 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.

Read full news article

Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight

2026-06-11 10:00:22

At Rs 157.57, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 5.0% on 11 Jun 2026, with unfilled sell orders and a frozen price, signalling a day dominated by supply overwhelming demand.

Read full news article

Bafna Pharmaceuticals Ltd Forms Golden Cross Amid Mixed Technical Signals and Recent Price Drop

2026-06-10 18:00:48

The 50-day moving average has crossed above the 200-day moving average for Bafna Pharmaceuticals Ltd, signalling a golden cross on 10 Jun 2026. However, the stock declined 4.97% on the day the cross formed, while some technical indicators present a mixed picture. This divergence between the moving averages and price action calls for a closer examination of the signal's reliability.

Read full news article

Bafna Pharmaceuticals Ltd is Rated Sell

2026-06-10 10:10:27

Bafna Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 10 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 4.99% Loss — Sellers Queue, No Buyers in Sight

2026-06-10 10:00:16

At Rs 165.86, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 4.99% on 10 Jun 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity.

Read full news article

Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 10% Gain — Buyers Queue, Sellers Absent

2026-06-09 10:00:16

At Rs 213.36, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 10% on 9 Jun 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 215.7

2026-06-09 09:40:32

Surging past its previous peaks, Bafna Pharmaceuticals Ltd touched a fresh 52-week high of Rs 215.7 on 09 Jun 2026, marking a remarkable rally of 186.47% over the past year. This milestone comes amid a sustained seven-day winning streak, underscoring the stock’s robust momentum despite a broadly subdued market backdrop.

Read full news article

Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 10.0% Gain — Buyers Queue, Sellers Absent

2026-06-08 10:00:15

At Rs 193.97, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 10.0% on 8 Jun 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

2026-06-04 10:00:22

At Rs 160.31, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5% on 4 Jun 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

View All News